Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry

BACKGROUND: PYRAMID was an international multicenter, noninterventional, postmarketing registry assessing long-term safety and effectiveness of adalimumab (Humira), as used in routine clinical practice. METHODS: Adult patients with moderately to severely active Crohn’s disease with or without prior...

Descripción completa

Detalles Bibliográficos
Autores principales: Loftus, Edward V, Reinisch, Walter, Panaccione, Remo, Berg, Sofie, Alperovich, Gabriela, Bereswill, Mareike, Kalabic, Jasmina, Petersson, Joel, Thakkar, Roopal, Robinson, Anne M, D’Haens, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701510/
https://www.ncbi.nlm.nih.gov/pubmed/30753510
http://dx.doi.org/10.1093/ibd/izz008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701510/
https://www.ncbi.nlm.nih.gov/pubmed/30753510
http://dx.doi.org/10.1093/ibd/izz008

Ejemplares similares